Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, ...
A top US Food and Drug Administration (FDA) official stated that the midterm congressional election results will not likely ...
As artificial intelligence (AI) permeates the regulatory world, experts said it won't take over regulatory professionals' ...
<i>Regulatory Focus</i> is the only source of timely, quality news and information fully dedicated to daily online coverage of the global regulation of healthcare products. An experienced team of ...
A top US Food and Drug Administration (FDA) enforcement official announced that the agency conducted more unannounced drug ...
More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on ...
Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. Regulatory Recon is ...
Sponsored Content] Health Canada’s 14 September 2026 interim policy introduces flexibility in ethics reporting, investigator ...
You are here: Homepage News & Insights Search Regulatory pathways for approving foreign drugs in China: A global integration perspective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results